- Home
- PHAT vs ITRN Comparison
PHAT vs ITRN Comparison
Compare PHAT & ITRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PHAT | ITRN |
|---|---|---|
| Founded | 2018 | 1994 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Electronic Components |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 942.6M | 817.2M |
| IPO Year | 2019 | 2005 |
Fundamental Metrics
Financial Performance| Metric | PHAT | ITRN |
|---|---|---|
| Price | $14.36 | $42.63 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 6 | 1 |
| Target Price | $17.33 | ★ $50.00 |
| AVG Volume (30 Days) | ★ 828.8K | 97.3K |
| Earning Date | 10-30-2025 | 11-18-2025 |
| Dividend Yield | N/A | ★ 4.70% |
| EPS Growth | N/A | ★ 8.81 |
| EPS | N/A | ★ 2.84 |
| Revenue | $147,190,000.00 | ★ $348,409,000.00 |
| Revenue This Year | $218.59 | $9.12 |
| Revenue Next Year | $84.38 | $10.70 |
| P/E Ratio | ★ N/A | $14.81 |
| Revenue Growth | ★ 460.30 | 5.20 |
| 52 Week Low | $2.21 | $28.96 |
| 52 Week High | $16.27 | $45.43 |
Technical Indicators
Market Signals| Indicator | PHAT | ITRN |
|---|---|---|
| Relative Strength Index (RSI) | 49.05 | 72.33 |
| Support Level | $14.12 | $39.24 |
| Resistance Level | $16.27 | $40.79 |
| Average True Range (ATR) | 0.72 | 1.30 |
| MACD | -0.12 | 0.34 |
| Stochastic Oscillator | 8.39 | 97.19 |
Price Performance
Historical ComparisonAbout PHAT Phathom Pharmaceuticals Inc.
Phathom Pharmaceuticals Inc operates as a clinical-stage biopharmaceutical company. The firm is focused on developing and commercializing novel treatments for gastrointestinal, or GI, diseases. Its product comprises vonoprazan, an oral small-molecule potassium competitive acid blocker medicine that blocks acid secretion in the stomach. Vonoprazan shows rapid, potent, and durable anti-secretory effects and has demonstrated clinical benefits in the treatment of gastroesophageal reflux disease, and in combination with antibiotics for the treatment of Helicobacter pylori infection.
About ITRN Ituran Location and Control Ltd.
Ituran Location and Control Ltd is a provider of location-based services. The company operates in two segments, namely Telematics services and Telematics products. The Telematics services segment consists of regionally-based stolen vehicle recovery (SVR) services, fleet management services, and value-added services comprised of personal locater services and concierge services. The Telematics product segment consists of short and medium-range two-way machine-to-machine wireless communications products that are used for various applications, including automatic vehicle location and automatic vehicle identification. Its geographical segments include Israel, Brazil, and Others. The company derives maximum revenue from Israel.